Brenntag Pharma: Adding Value and Reducing Distribution Complexity
Interview with Catarina Gil Forte, Head of Industry for Synthesis & Biopharma at Brenntag Pharma.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.